Guidance for reporting a protocol of a systematic review and meta analysis
This advice is relevant to protocols of systematic reviews and is based on the PRISMA-P statement Read more
The following information was originally published here.
Go to checklistTitle
1a Identification
Identify the report as a protocol of a systematic review.
1b Update
If the protocol is for an update of a previous systematic review, identify as such.
Registration
2.
If registered, provide the name of the registry (such as PROSPERO) and registration number.
Authors
3a Contact
Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of corresponding author.
3b Contribution
Describe contributions of protocol authors and identify the guarantor of the review.
Amendments
4.
If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, state plan for documenting important protocol amendments.
Support
5a Sources
Indicate sources of financial or other support for the review.
5b Sponsor
Provide name for the review funder and / or sponsor.
5c Role of sponsor or funder
Describe roles of funder(s), sponsor(s), and / or institution(s), if any, in developing the protocol.
Introduction
6. Rationale
Describe the rationale for the review in the context of what is already known.
7. Objectives
Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, comparators, and outcomes (PICO).
Methods
8. Eligibility criteria
Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, language, publication status) to be used as criteria for eligibility for the review.
9. Information sources
Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other grey literature sources) with planned dates of coverage.
10. Search strategy
Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated.
11a Study records - data management
Describe the mechanism(s) that will be used to manage records and data throughout the review.
11b Study records - selection process
State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, screening, eligibility and inclusion in meta-analysis).
11c Study records - data collection process
Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for obtaining and confirming data from investigators.
12. Data items
List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data assumptions and simplifications.
13. Outcomes and prioritization
List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale.
14. Risk of bias in individual studies
Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study level, or both; state how this information will be used in data synthesis.
15a Data synthesis
Describe criteria under which study data will be quantitatively synthesised.
15b Data synthesis
If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ).
15c Data synthesis
Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression).
15d Data synthesis
If quantitative synthesis is not appropriate, describe the type of summary planned.
16. Meta-bias(es)
Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies).
17. Confidence in cumulative evidence
Describe how the strength of the body of evidence will be assessed (such as GRADE).
To acknowledge this checklist in your methods, please state "We used the PRISMA-P checklist when writing our report [citation]". Then cite this checklist as Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1..
The PRISMA-P elaboration and explanation paper is distributed under the terms of the Creative Commons Attribution License CC-BY